Kimberly S. Huggler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kimberly S. Huggler has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Carlos A. Mellado Fritz
Morgridge Institute for Research, Madison, USA
2 shared publications - Gavin R. Chang
Department of Biochemistry, University of Wisconsin–Madison, Madison, USA
2 shared publications - Jason R. Cantor
Morgridge Institute for Research, Madison, WI 53715, USA
2 shared publications - Kyle M. Flickinger
Morgridge Institute for Research, Madison, USA
2 shared publications - Andres Dajles
Department of Biostatistics, University of Iowa, 145 N. Riverside Drive, Iowa City, IA 52242, USA
1 shared publication Christian M. Capitini
Department of Pediatrics, University of Wisconsin–Madison, Madison, USA
1 shared publication
Latest Publications
- 7 May 2026
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 72 (6) , 703-704
Inter-Instrument Imprecision Complements Bias in Evaluating LDL-C Method Performance
- 7 May 2026
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 72 (6) , 703-704
Inter-Instrument Imprecision Complements Bias in Evaluating LDL-C Method Performance
- 16 January 2026
- Published by Springer Nature in Nature Metabolism
- Vol. 8 (1) , 215-236
Hexokinase detachment from mitochondria drives the Warburg effect to support compartmentalized ATP production
Hexokinase (HK) catalyses the phosphorylation of glucose to glucose 6-phosphate, marking the first step of glucose metabolism. Most cancer cells co-express two homologous HK isoforms, HK1 and HK2, which can each bind the outer mitochondrial membrane (OMM). CRISPR screens performed across hundreds of cancer cell lines indicate that both isoforms are dispensable for growth in conventional culture media. By contrast, HK2 deletion impaired cell growth in human plasma-like medium. Here we show that this conditional HK2 dependence can be traced to the subcellular distribution of HK1. Notably, OMM-detached (cytosolic) rather than OMM-docked HK supports cell growth and aerobic glycolysis (the Warburg effect), an enigmatic phenotype of most proliferating cells. We show that under conditions promoting increased translocation of HK1 to the OMM, HK2 is required for cytosolic HK activity to sustain this phenotype, thereby driving sufficient glycolytic ATP production. Our results reveal a basis for conditional HK2 essentiality and suggest that demand for compartmentalized ATP synthesis explains why cells engage in aerobic glycolysis.
- 16 January 2026
- Published by Springer Nature in Nature Metabolism
- Vol. 8 (1) , 215-236
Hexokinase detachment from mitochondria drives the Warburg effect to support compartmentalized ATP production
Hexokinase (HK) catalyses the phosphorylation of glucose to glucose 6-phosphate, marking the first step of glucose metabolism. Most cancer cells co-express two homologous HK isoforms, HK1 and HK2, which can each bind the outer mitochondrial membrane (OMM). CRISPR screens performed across hundreds of cancer cell lines indicate that both isoforms are dispensable for growth in conventional culture media. By contrast, HK2 deletion impaired cell growth in human plasma-like medium. Here we show that this conditional HK2 dependence can be traced to the subcellular distribution of HK1. Notably, OMM-detached (cytosolic) rather than OMM-docked HK supports cell growth and aerobic glycolysis (the Warburg effect), an enigmatic phenotype of most proliferating cells. We show that under conditions promoting increased translocation of HK1 to the OMM, HK2 is required for cytosolic HK activity to sustain this phenotype, thereby driving sufficient glycolytic ATP production. Our results reveal a basis for conditional HK2 essentiality and suggest that demand for compartmentalized ATP synthesis explains why cells engage in aerobic glycolysis.
- 2 May 2025
- Published by Springer Nature in Nature Metabolism
- Vol. 7 (6) , 1150-1167
Cytosolic NADK is conditionally essential for folate-dependent nucleotide synthesis
Nicotinamide adenine dinucleotide kinase (NADK) catalyses the phosphorylation of NAD+ to produce NAD phosphate, the oxidized form of NADPH, a cofactor that serves a critical role in driving reductive metabolism. Cancer cells co-express two distinct NAD kinases that differ by localization (NADK, cytosol; NADK2, mitochondria). CRISPR screens performed across hundreds of cancer cell lines indicate that both are dispensable for growth in conventional culture media. By contrast, NADK deletion impaired cell growth in human plasma-like medium. Here we trace this conditional NADK dependence to the availability of folic acid. NADPH is the preferred cofactor of dihydrofolate reductase (DHFR), the enzyme that mediates metabolic activation of folic acid. We find that NADK is required for enabling cytosolic NADPH-driven DHFR activity sufficient to maintain folate-dependent nucleotide synthesis under low folic acid conditions. Our results reveal a basis for conditional NADK essentiality and suggest that folate availability determines whether DHFR activity can be sustained by alternative electron donors such as NADH.
- 2 May 2025
- Published by Springer Nature in Nature Metabolism
- Vol. 7 (6) , 1150-1167
Cytosolic NADK is conditionally essential for folate-dependent nucleotide synthesis
Nicotinamide adenine dinucleotide kinase (NADK) catalyses the phosphorylation of NAD+ to produce NAD phosphate, the oxidized form of NADPH, a cofactor that serves a critical role in driving reductive metabolism. Cancer cells co-express two distinct NAD kinases that differ by localization (NADK, cytosol; NADK2, mitochondria). CRISPR screens performed across hundreds of cancer cell lines indicate that both are dispensable for growth in conventional culture media. By contrast, NADK deletion impaired cell growth in human plasma-like medium. Here we trace this conditional NADK dependence to the availability of folic acid. NADPH is the preferred cofactor of dihydrofolate reductase (DHFR), the enzyme that mediates metabolic activation of folic acid. We find that NADK is required for enabling cytosolic NADPH-driven DHFR activity sufficient to maintain folate-dependent nucleotide synthesis under low folic acid conditions. Our results reveal a basis for conditional NADK essentiality and suggest that folate availability determines whether DHFR activity can be sustained by alternative electron donors such as NADH.